Form 4: Chemed Corp Insider Sells Shares
Statement of Changes in Beneficial Ownership
Kevin J. McNamara, President and CEO of Chemed Corp, reported a sale of 2,000 shares of capital stock on May 1, 2026.
Summary
- Kevin J. McNamara, who holds the positions of Director, Officer (President and CEO) at Chemed Corp, has reported a transaction involving company stock.
- On May 1, 2026, Mr. McNamara sold 2,000 shares of Chemed Corp's capital stock.
- The sale was executed at a weighted average price of $421.13 per share, with individual transactions ranging from $418.99 to $424.95.
- Following this transaction, Mr. McNamara beneficially owns 90,219 shares of capital stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing. While insider selling can be a point of concern, this Form 4 is a routine disclosure of a transaction and does not provide information about the company's performance or future prospects.
Negatives
- Insider selling can sometimes be perceived negatively by the market, although the reasons for such sales are not always indicative of a company's future performance.
Future Outlook
No forward-looking statements or guidance are present in this filing.
Management Comments
- The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and do not inherently signal company performance. The sale by a key executive like the President and CEO warrants attention, but the context of the sale (e.g., diversification, personal financial planning) is not provided in the filing.
Stakeholder Impact
- Shareholders may observe this transaction, but the impact is not immediately clear without further context on the reasons for the sale.
Key Dates
| Date | Description |
|---|---|
| 05/01/2026 | Date of transaction (sale of 2,000 shares of capital stock by Kevin J. McNamara). |
| 05/04/2026 | Date of signature for the Form 4 filing. |
Keywords
Chemed Corp, Insider Trading, Form 4, SEC Filing, Stock Sale, Capital Stock, Kevin J. McNamara
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.